|drug3151||Pulmonary function testing Wiki||1.00|
|drug2035||Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets Wiki||1.00|
|drug2036||Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU. Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
The associated use of Ivermectin, aspirin, dexamethasone, and enoxaparin (in different combinations and doses) will reduce the impact of COVID infection 19, the need of admission to the intensive care unit, and mortality.
Description: Number of patients who did not go to a more severe stage of disease or die (i.e. they neither go from mild to moderate or severe, nor go from moderate to severe or die, if they had been already enrolled in a severe condition)Measure: Patients Who Improved Their Condition or Did Not Worsen it Time: 7 days
Description: Number of patients needing ICU-treatment including mechanical ventilation after 2-week treatmentMeasure: ICU-treated Patients After 2-week Treatment Time: 14 days
Description: Patients who died within 30 days after enrollmentMeasure: Mortality Time: 30 days
Description: Patients who needed dose adjustment of any of the drugs involved in the treatment protocolMeasure: Patients Needing Drug Dose Adjustment Time: 14 days
Description: Patient presenting serious adverse eventsMeasure: Adverse Events Time: 14 days
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports